Analysis of variables and interactions among variables associated with a sustained virological response to pegylated interferon alfa-2a plus ribavirin in hepatitis C virus genotype 3-infected patients | Zendy

Hafsa Aziz | Zendy; Abida Raza | Zendy; Yasir Waheed | Zendy; Uzma Gill | Zendy; Muzaffar Lateef Gill | Zendy

Open Access

Analysis of variables and interactions among variables associated with a sustained virological response to pegylated interferon alfa-2a plus ribavirin in hepatitis C virus genotype 3-infected patients

Author(s) -

Hafsa Aziz,

Abida Raza,

Yasir Waheed,

Uzma Gill,

Muzaffar Lateef Gill

Publication year - 2012

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2012.03.012

Subject(s) - ribavirin , pegylated interferon , virology , medicine , genotype , hepatitis c virus , hepatitis c , virus , biology , gene , biochemistry

The recommended standard therapeutic regimen for chronic hepatitis patients with hepatitis C virus (HCV) genotype 3 is pegylated interferon plus ribavirin for 24 weeks. The aim of the present study was to evaluate treatment efficacy and variables predictive of treatment success, interactions among variables contributing to a response to therapy, and the utility of the rapid virological response (RVR; week 4 virological response) to predict treatment outcomes in HCV genotype 3-infected patients in routine clinical practice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research